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ABSTRACT 
Objective: The purpose of this study was to develop and in vitro evaluation phytosome of terbinafine HCL to enhance the bioavailability for oral 
route. 
Methods: The novel phytosome of terbinafine hydrochloride (TFH) was formulated with the molar ratio (1:2) of drug and phospholipid by using 
solvent evaporation technique. The resulting TFH-PC was determined by means of particle size analyzer (PSA), percentage yield, microscopy, drug 
content, transmission electron microscopy (TEM). Substantial contact of terbinafine HCL with phospholipids was completed through Fourier 
transforms infrared spectroscopy (FTIR). 
Results: The all relevant results of TFH-PC were showed that the percentage entrapment efficiency of formulation was found in 76% to 90%. In 
vitro release data were exhibited approximately 65% to 79% of the drug released from the TFH-PC formulation by using dialysis membrane 
technique. Therefore, Formulation (F3) was accomplished that phytosome contain the superior physical characters and compatibility with drug and 
phospholipids than to make it easy to overcome the competence of drug to pass the lipid-rich bio-membrane.  
Conclusion: In present work, terbinafine loaded phytosome was formulated for increasing the oral bioavailability of selected drug. Hence, TER-HCL 
phytosome were effectively improved the absorption of drug in form of phospholipids complex. 
Keywords: Terbinafine HCL phytosome (TFH-PC), Solvent evaporation method, FTIR, TEM 
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INTRODUCTION 
From the ancient time, various herbal drugs have been familiar to 
the development of the well creations in biological activities of 
phyto-pharmacological science with their superior advantages for 
various herbal remedies [1]. The phyto-chemical and phyto-herbal 
drugs are found in the nature of polar solvents (water). When it 
gives orally then they exhibit the reduce profile of drug. Although 
they cannot be penetrate through inactive form due to larger 
molecular mass and reduced lipid polymer profile [2]. A number of 
phyto-drug and its effectiveness to go beyond the lipid-rich genetic 
membrane and that cause the resulting reduce oral availability of 
drugs [3]. Phytocomplexes are formulated with adding of soya 
phospholipids and elected of drug. Subsequently, by taking place of 
physically and chemically character of the drug and phoshpolipid 
with spectroscopic analysis after it taking into consideration as a 
novel entities [4]. Phytosomal formulation are included as capacity 
to improve the movement of drug inside the body. This system can 
be typically utilize in the curing of severe and long term hepatic 
infection due to toxic metabolite or transitive sources and nature of 
degenerative substance. Thus, it may be too helpful in the treatment 
of inflammation of various chemical and compositions of other drugs 
[5]. The phytosomes are prepared through phospholipids molecules 
and connected to the tiny cell like division. As a result, phytosome 
has become the pioneer advancement towards the standardized 
herbal formulation for enhancement of absorption of poor boilable 
drug [6]. The leading of this phytosomal formulations were 
produced in 1989 by Italians researcher congregation. However, this 
technology was based on the herbal-chemical investigation of clear 
polyphones compounds with their potent bonding potency of 
phospholipids and whole plant tissue [7]. By this knowledge, it can 
raise the superior assistance for the delivery of medicament at the 
tissue site for well incorporation of drug and lipids [8]. 
Terbinafine hydrochloride is a synthetic allylamine antifungal agent. 
It’s for the most part of BCS group IInd. Currently terbinafine 
hydrochloride is applied as an antifungal agents beside the 
treatment of fungal infection of toes and fingernails that is occur 
mostly from fungus substance onychomycosis. It is exhibit the in 
vitro activity adjacent to the largest part of the strain of other 
microbes such as candida albicans. Terbinafine hydrochloride is a 
novel effective antifungal substance that is little soluble in water. For 
that reason, it is the slow release rate with water but it is highly 
soluble in methanol. Consequently, drug concentration with the 
body fluids which is lesser than the Minimum Inhibitory 
Concentrations (MIC). There are various pharmaceutical and 
chemical study of the drug required the valuable analytical practice 
or method for better controlling of in vitro and in vivo profile. After 
that, numerous techniques have been established to confirm its 
evaluation in organic and natural materials for the better action of 
drug in treatment of fungal infection at body site [9, 10]. 
MATERIALS AND METHODS  
Materials 
For the development of phytosome, terbinafine hydrochloride was 
obtained from Macleod pharmaceuticals Pvt. Ltd, baddi, soya 
phosphatidylcholine (leciva-S25) was received from web life science 
pvt. ltd, and methanol was used the HPLC grade. 
Methodology 
Estimation of UV spectra of terbinafine hydrochloride 
The UV Spectra of pure drug gets examined by UV 
spectrophotometer shimadzu. Stock solution of terbinafine HCL was 
made through dilute of 10 mg pure drug in 50 ml of methanol. After 
that, make the dilutions in the series 5-40 µg/ml with the methanol. 
Then the solutions of TER-HCL were examined through U. V. range 
at 224 nm with methanol as blank. Further UV curve was plotted 
and all outcomes were recorded and determined as well as [11]. 
Solubility studies 
In this Study, the 50 mg amount of drug of terbinafine was dissolved 
in 3 ml of aqueous solvent of water and other solvent like methanol, 
chloroform, and buffer containing potassium dihydrogen phosphate 
6.8 pH, acidic 1.5 pH. Later than the solution is filled in culture tube 
and that tightly blocked. All samples were kept at water bath shaker 
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for 24 h at room temperature. Afterward, each one was centrifuged 
at 15000 rpm for 15 min and supernatant was formed. It’s scanned 
through UV at 224 nm [12]. 
Partition coefficient of drug 
For measuring of drug lipid nature of selected drug, partition 
coefficient analysis technique used as n-octanol and water system, it 
is done by shake flask process. The requisite amount of terbinafine 
HCL was dissolved in 10 ml of water/n-octanol system and it is kept 
for 24 h then separated the two layers of water and n-octanol in 
each tube for centrifugation and then absorbance was taken at λ max 
224 after making suitable dilution [13]. 
Drug-excipient interaction study by FT-IR 
FT-IR used as device to make the contact among drug and 
phospholipids. For this process, drug and excipient were taken in 
ratio of 1:2. The both sample were examined through FT-IR 
underneath the array of 400-4000 cm-1. After that, obtained 
spectrum of actual drug and excipient were checked in the least 
incongruity and physical changes also [14]. 
Preparations of terbinafine hydrochloride phytosome 
The phytosome of terbinafine HCL and soya lecithin were developed 
with the solvent evaporation method. The precise amount of drug 
and phospholipid was taken in 250 ml RBF (round bottom Flask) 
with each molar part of drug and phospholipid ratio (1:2). After that 
TER-PC were refluxed at temp range of 40 °C for 2 h with the 
methanol. At that time the apparent solution of drug and 
phospholipids were dried up at 60 °C by way of vacuum evaporator 
to get rid of unwounded particle from clear the solvents for getting 
better formation terbinafine-phospholipid complex. The formulated 
solution of TER-PC was placed in the desiccators for overnight. After 
overnight, than the solution become hydrate with phosphate buffer 
containing pH 6.8 with constant stirring to obtain the phytosome 
complex, after that phytosome was kept in amber color glass bottle 
and stored in the cool place at room temp [15]. 
 
Table 1: Composition of various phytosome formulations containing terbinafine hydrochloride and phospholipid 
S. No. Formulation code Drug: soya lecithin (Molar ratio) Methanol (ml) 
1 F1 1:1 10 
2 F2 1:1.5 10 
3 F3 1:2 10 
4 F4 1:2.5 10 
5 F5 1:3 10 
6 F6 1:4 10 
*Value is expressed as for the experiment (mean±SD, n=3) 
 
Evaluation of prepared phytosome 
Microscopic view 
For the microscopic evaluation of phytosome, primarily the drop of 
TER-PC was placed on top of the glass slide and it enclosed with a 
wrap slip in microscopy. Subsequently, Microscopic image of the 
complex was revealed at 40 angles with superior configuration of 
phytosome [16]. 
Particle size analysis 
The particle size study of prepared formulation was done by 
Malvern zetasizer at 25 °C by applying laser light dispersion system. 
Although, this technique is primed with argon laser based procedure 
as well as it is widely use to assessment of particle size and 
distribution. The 100 mg of phytosome was grind and mixed in 10 
ml of distill water prior to study [17]. 
Determination of drug content  
Drug content of phytosome was performed as a result of suspending 
the exactly mass of 100 mg complex with 10 ml methanol. After 
making appropriate dilutions range for absorbance. It was estimated 
with UV Spectroscopy at 224 nm and drug content was established 
on the basis of definite absorbance [18]. 
Entrapment efficiency  
The entrapment efficiency of phytosome was determined by using 
cooling centrifuged systems at 15000 rpm for 15 min at 4 °C. The 
entrapment ability of the drug with phospholipids complex was 
assessed through the UV spectroscopy. And the percentage 
entrapment efficiency was fig. out by specified formulas [19]. 
%   =
                      −                          
                    
 100 
FT-IR spectroscopy 
The establishment of the phytosome complex was validated 
through FT-IR spectroscopy by means of modulating the complex 
with the range of the particular components and their physical 
mixtures. FT-IR spectroscopy was considered as useful tool for 
managing the dependability of phytosomal drug whereas micro-
dispersion in water or else behind incorporation of generally pure 
drug [20]. 
Transmission electron microscopy (TEM)  
Morphological inspection of phytosome of terbinafine HCL in 
powder and several selected terbinafine HCL-PC complex 
formulations were examined with TEM. Phytosome formulation was 
diluted with a 0.01 % and shake for 10 min. A drop of the 
phospholipid complex was kept on top of a carbon-coated copper 
grid, avoiding a thin coating. The film of the PC was air-dried and 
then imaged [21]. 
In vitro release profiles  
The release studies of terbinafine HCL phytosome were evaluated by 
a dialysis technique using a dialysis membrane (molecular weight 
cutoff of 3500 Da). The release studies were performed in PB 
solution (pH 6.8). A total 3 ml of phytosome containing drug sample 
were transferred into a dialysis membrane and then immersed into 
50 ml of PB at room temp with gentle shaking. Subsequently, 
According to the predesigned time intervals, 3 ml sample of the 
release medium was withdrawn and subsequently, 3 ml sample of 
the fresh medium was placed in to the release medium. The 
accumulative drug release of the phytosome was determined as a 
percentage of the drug released [22].  
Drug release kinetic studies  
In the current study, the in vitro release studies of the formulation 
was analyzed by this process, the data of the prepared formulation 
was placed in different equations and determine the kinetics model 
and percentage release of optimized formulation of phytosome. 
Thus, The kinetic models were used for determine the percent 
release of drug as well as by Zero-order equation, First-order, 
Higuchi’s model and Korsmeyer-Peppas equation. 
RESULTS AND DISCUSSION 
Results of preformulation study of drug 
Organoleptic properties of drug terbinafine hydrochloride found to 
be as per USP monograph. The organoleptic properties of 
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*Value is expressed as for the experiment (mean±SD,
which is of the pure drug. Hence, the drug sample was f
 
U V spectroscopy determination of absorption m
Absorption maxima of terbinafine HCL were found to be at 224 nm similar 
 
Preparation of standard curve of terbinafine h
Fig. 2: Graph of standard calibration curve of t
The calibration curve for terbinafine hydrochloride
The absorbance was measured at 224 nm. The calibration curve of 
Y= 0.231x+0.006 and R2value 0.998, which shows good linearity as shown in 
Sharma et al. 
Int J App Pharm, Vol 12, Issue 5, 2020, 




 Fully Powder 
Bitter 
 n=3) 
 3: Melting point of terbinafine hydrochloride 
Observed melting point Reference melting 
196-200 °C 195-198 °C 
 n=3), The melting point of terbinafine hydrochloride was found to be in range 196±200
ree from all type of impurities [23]. 
axima in methanol 
to literature as shown in fig. 1. 
Fig. 1: UV spectrum of terbinafine HCL 
 
ydrochloride in methanol 
erbinafine HCL in methanol, *Value is expressed as for the 
 was obtained by using the 5 to 4 µg/ml concentration of terbinafine hydrochloride








experiment (mean±SD, n=3) 
 in methanol. 
 
Solubility studies 
The excess amount of terbinafine hydrochloride was dissolved 
separately in the below solvents and shake constantly
  
Fig. 3: Solubility study of drug in different solvents, (mean±SD, n=3)
Terbinafine hydrochloride was found to be highly soluble in methanol ranging 323.08±6.612 and sparingly soluble in ethanol, c
slightly soluble in water. Solubility of terbinafine hydrochloride was determined with different solvents as sho
 
Partition coefficient determination 
ble 4: Partition coefficient determination of 
Partition coefficient of drug 
Terbinafine hydrochloride 
*Value is expressed as for the experiment (mean±SD,
 
The partition coefficient of terbinafine HCL in n
 
FT-IR of terbinafine hydrochloride and excipient
Fig. 4: FT-IR s
The FT-IR spectra of terbinafine HCL were shown in the 
of terbinafine hydrochloride confirmed the purity and integrity below in IR spectra
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sample were taken and absorbance of sample was recorded usi




Solvent system Log P value 
Water: n-octanol 1.3765±0.0008
 n=3) 
-octanol: water was found to be 1.3765±0.0008; this indicates that 
 
pectra of pure terbinafine hydrochloride, (mean±SD, n=3)
 




. Solutions of drug, later than 24 h, 
ng 








the drug is lipophilic in nature. 
 
 




The FTIR spectra of soya lecithin were shown in the 
chain). This observation confirmed the purity and integrity of the lecithin
FT-IR of pure drug and physical mixtures 
Fig. 6: FT-IR spectra of 
All peaks of this mixture were manifested that resultant peaks of drug are existent in the
interaction was marked in this physical mixture
Characterization of phytosome formulation 
Appearance of phytosome 
Fig. 7: Terbinafine
From the above fig. 7. We observe the milky white appearance.
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 5: FT-IR spectrum of soya lecithin, (mean±SD, n=3) 
 
fig. 5. IR absorption peaks of soya lecithin at 3332.63 cm-1(C
. 
terbinafine hydrochloride and soya lecithin, (mean±SD, n=3)
 
 beyond spectrum with excipient
 fig. 6. 
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The photomicrograph of terbinafine phytosome formulation manifested that particles present in uniform shape without any 
 
Fig. 8: Photomicrograph 
Particle size analysis 
Fig. 9: Particle
The Particle size with polydispersity index of formulation 
formulation was showed the high loading entrapment efficiency of the phytosome.
Determination of drug content 
 
Table 5







*Value is expressed as for the experiment (mean
The drug content of phytosome formulation was 
of all formulations was found to be satisfactory. Hence, the process adopted for the phytosome formulations was found to be s
above table 5. 
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of terbinafine loaded phytosome, (mean±SD, n=3)
 
 size distribution of phytosome formulation F3, (mean±SD, n=3)
 
(F3) was 425±112.3 nm with PDI 0.275±0.000
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 in fig. 9. Hence, the particle size of 
The percentage drug content 
uitable. It is depicted 
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Table 6: Different ratio of drug and phospholipid for phytosome formulation 
F. Code Drug: soya lecithin (Molar ration) %EE 
F1 1:1 76.3203±0.321 
F2 1:1.5 83.1168±1.212 
F3 1:2 88.0519±0.212 
F4 1:2.5 90.6514±0.191 
F5 1:3 80.735±0.090 
F6 1:4 75.584±0.231 
*Value is expressed as for the experiment (mean±SD, n=3) 
 
The % drug entrapment efficiency of phytosome formulation was found to be 75.584±0.231 to 90.6514±0.191 which is represented in table 6. 
Hence, it is shown the better entrapment efficiency with drug and phytosome. 
FT-IR spectroscopy of phytosome formulation 
 
 
Fig. 10: FT-IR of final formulation F3, (mean±SD, n=3) 
 
The FTIR spectra of final formulation (F3) represent that characteristic peak of terbinfine hydrochloride was not appeared in the phytosome spectra 
that which indicates that drug was completely encapsulate in the phytosome fig. 10. 
Transmission electron microscopy (TEM)  
 
 
Fig. 11: TEM image of selected formulation F3 (mean±SD, n=3) 
 
TEM image of TER-PC was established that the drug is completely encapsulated with the phytosome. The prepared formulation of terbinafine 
hydrochloride was exhibiting the effective results of physical entrapment of drug with Phospholipids molecules. Hence, it reveals the formation of 
phytosome in form of uniform micellar shape with selected drug fig. 11.  
 
In vitro drug release profile 
 
Fig. 12: Drug release profile of selected phytosome formulation F3
The percentage of drug release from the formulation (F3) was determined and cumulative % drug release compared with terbinafi
phytosome formulations (F3). It was observed that the formulation (F3) has highest drug release as 79.437±0.572%. 
In vitro drug release kinetic 
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 was given below, (mean±SD, n=3). 
Fig. 13: Zero order graph of formulation F3 
 











Korsmeyer peppas model 
Fig. 
Table 
Formulation name Zero order 
R2 
 TER-PC 0.669 
*Value is expressed as for the experiment (mean±SD,
 
Mathematical models of kinetic release are commonly used to 
predict the release process of the prepare formulation and compare 
the release profile. For the optimized formulation, the % drug 
release vs time (zero order), log percent drug remaining vs time 
(first order), log per cent drug release vs square root of time 
(Higuchi plot), and log of log % drug release vs. log time (Korsmeyer 
and Peppas Exponential Equation) were plotted. In each case, R
value was calculated from the graph and reported in
to fig. 16. Considering the determination coefficients, Korseymer 
peppas model was found (R2=0.951) to fit the release data best. 
Hence, that the drug was released from terbinafine phytosome by a 
controlled mechanism.  
CONCLUSION 
The main goal of these oral formulations to provide the delivery of 
medicament or drug at the body site and tissue and to attain the 
desired plasma profile of drug intended for a definite period of time. 
However, shortened release of drug may cause the shorter residence 
instances and lower bioavailability of dosage form in the 
gastrointestinal tract. For avoiding such difficulties related to the 
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Fig. 15: Higuchi order graph of formulation F3 
 
16: Korsmeyer peppas order graph of formulation F3 
 
7: Kinetic equation parameter of F3 formulation 
First order Higuchi 
K0 R2 K0 R2 K0 
3.297 0.829 -0.028 0.889 18.83
 n=3) 
2 
 table 7. Fig. 13, 
drug, thus phytosome drug delivery system was effectively 
developed that exhibit the prohibited release of formulation and 
functionally overcome the lower bioavailability 
terbinafine hydrochloride. For optimized formulation, 
release was done in dihydrogen phosphate buffer (PB) containing 
pH 6.8 by means of dialysis membrane techniques. In addition, 
selected formulation (F3) vindicated the expected relea
approximately 80% designed for complete phase of time for 24 (h). 
Further, release kinetics of drug was followed the koresmeyer 
peppas modal for controlled formulation.
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